Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C R Cimochowski
Pharmacokinetic and in Vivo Studies With Azithromycin (CP-62,993), a New Macrolide With an Extended Half-Life and Excellent Tissue Distribution.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
A Novel Engineered VEGF Blocker With an Excellent Pharmacokinetic Profile and Robust Anti-Tumor Activity
BMC Cancer
Cancer Research
Oncology
Genetics
Successful Haemostasis With Extended Half-Life Recombinant Factor VIII in Circumcision
Turkish Journal of Haematology
Hematology
In Vitro and in Vivo Intraleukocytic Accumulation of Azithromycin (CP-62, 993) and Its Influence on Ex Vivo Leukocyte Chemiluminescence.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Distribution of Cytochrome Oxidase in Rat Brain: Studies With Diaminobenzidine Histochemistry in Vitro and [14C]Cyanide Tissue Labeling in Vivo
Journal of Cerebral Blood Flow and Metabolism
Neurology
Cardiovascular Medicine
Cardiology
Macrolide Resistance Mechanisms inEnterobacteriaceae: Focus on Azithromycin
Critical Reviews in Microbiology
Applied Microbiology
Biotechnology
Microbiology
Medicine
Interaction of the Macrolide Antibiotic Azithromycin With Lipid Bilayers: Effect on Membrane Organization, Fluidity, and Permeability
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Azithromycin Treatment Failure in Macrolide-Resistant Mycoplasma Pneumoniae Pneumonia
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Psy65 - Real-World Data Analysis of Us Claims Data on Coagulation Factor Ix Dispensation and Expenditures in Patients With Severe Hemophilia B: Standard Half-Life vs. Extended Half-Life Products
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PEGylation Extends Circulation Half-Life While Preserving in Vitro and in Vivo Activity of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)
PLoS ONE
Multidisciplinary
